Transposagen Biophamaceuticals Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $4.3M
Latest Deal Amount
  • Investors
  • 1

Transposagen Biophamaceuticals General Information

Description

Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 535 West Second Street
  • Suite L102
  • Lexington, KY 40508
  • United States
+1 (859) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transposagen Biophamaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Jun-2013 $4.3M 00.000 Completed Generating Revenue
3. Angel (individual) 18-Jul-2012 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-Dec-2011 $725K $725K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Transposagen Biophamaceuticals’s complete valuation and funding history, request access »

Transposagen Biophamaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and develo
Biotechnology
Lexington, KY
20 As of 2015
00.000
0000000000 00.000

0000000

is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
00000 000000000000000 000 0000000000000
Cambridge, United Kingdom
000 As of 0000
00000
0000 0000-00-00
000000&0 00000

0000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000000000000
Berkeley, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transposagen Biophamaceuticals Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom 000 00000 000000&0 00000
0000000 0000000000 Venture Capital-Backed Berkeley, CA 00 00000 00000000000 00000
0000000 Corporation Seoul, South Korea 00
0000000 0000000000 Formerly VC-backed Menlo Park, CA 000 00000 000000&0
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Transposagen Biophamaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Eric Ostertag Ph.D Chief Executive Officer & President
To view Transposagen Biophamaceuticals’s complete executive team members history, request access »

Transposagen Biophamaceuticals Board Members (1)

Name Representing Role Since
Nishan Silva MD Self Board Member 000 0000
To view Transposagen Biophamaceuticals’s complete board members history, request access »

Transposagen Biophamaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transposagen Biophamaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Transposagen Biophamaceuticals’s complete investors history, request access »